CTRE

ANALYST NOTE: CTRE (CareTrust REIT, Inc.) Date: 2026-06-13 Current Price: $37.06

1. Structural Readiness

• State: Forming.
• Aggressive/Pre-Breakout Entry: Not recommended as a standalone signal. A forming coil is a partial readiness signal, not a confirmed entry.
• Breakout Level: Not yet fired.
• Current Price: $37.06.
• Extension: Not applicable (price has not extended from a confirmed breakout).
• ATR Context: Current ATR is 2.8% (productive). This sits within the historical "sweet spot" (4-6% is high, but 2.8% indicates moderate volatility suitable for positioning, though not the extreme volatility often seen in momentum breakouts).

2. Thesis Layer

• Thesis Classification: TACTICAL.
• Macro Thesis: There is no named secular thesis attached to this specific setup at this date. The investment case is not driven by a specific macro narrative (e.g., "AI infrastructure boom" or "rate cut cycle") but is strictly setup-led.
• Judgment Criteria: The conviction must be derived entirely from the quality of the technical setup (the forming coil) and the underlying business fundamentals (growth, guidance, asset quality). Do not invent a macro thesis to justify the position.

3. The Business

CareTrust REIT, Inc. is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing facilities (SNF), senior housing communities, and other healthcare-related properties.

• Portfolio Composition: As of March 31, 2026, the company owned or leased 417 facilities (38,512 operational beds/units) across 32 U.S. states and the United Kingdom. The highest concentration of rental income is in California, the U.K., Texas, and Tennessee.
• Business Model: The company operates primarily on a triple-net lease model with independent operators. As of Q1 2026, the company collected 100% of contractual rent and interest, indicating high tenant credit quality and collection stability.
• Recent Activity & Growth:
• Acquisitions: Since April 2026, the company closed 12 transactions totaling approximately $865 million. Year-to-date (as of May 2026), they closed approximately $1.1 billion of investments at a blended stabilized yield of 8.9%.
• Diversification: The portfolio includes $705 million in U.S. skilled nursing/senior housing triple-net, $225 million in U.S. loans (secured by SNFs), $160 million in U.K. care homes, and the remainder in a SHOP (Senior Housing Operating Portfolio) platform.
• Strategic Shift: In Q4 2025, the company began utilizing the RIDEA structure to establish a SHOP platform, completing its first SHOP acquisition in December 2025.
• Financial Health:
• Coverage: EBITDAR rent coverage in the stabilized triple-net portfolio is 2.25x; EBITDARM coverage is 2.79x.
• Credit: Moody's upgraded the company to investment grade.
• Liquidity: Subsequent to March 31, 2026, the company borrowed $350 million net on its revolving facility and settled 9.5 million shares under forward contracts for $363.6 million in gross proceeds.

4. Archetype and Conviction

• Archetype: Growth Leader.
• Rationale: The company is demonstrating clear top-line and per-share growth. Management reported a 14% year-over-year FFO per share growth and raised 2026 full-year guidance for normalized FFO per share by a midpoint of 14.8% compared to 2025. The dividend was increased by 16.4%.
• Valuation Context: The financial spine indicates a forward consensus EPS of $1.49 for FY1 and $1.60 for FY2. The current price of $37.06 implies a forward P/E ratio of approximately 24.8x (based on FY1), which is consistent with a growth-oriented REIT trading at a premium to value, supported by the investment-grade upgrade and double-digit FFO growth.
• Conviction Stack:
• Thesis Strength: Low (Tactical/Setup-led only).
• Evidence Quality: High. Multiple primary sources (earnings transcripts, SEC filings) confirm strong execution, asset growth, and credit upgrades.
• Structural Quality: Moderate to High. The forming coil suggests accumulation, but the lack of a confirmed breakout means the structural quality is unproven.
• Rerating Potential: Moderate. The upgrade to investment grade and the shift toward a SHOP platform (which typically commands higher multiples than triple-net) provide a pathway for multiple expansion if the setup confirms.

5. Invalidations, Strengths, and Gaps

• Gaps in Evidence:
• Breakout Confirmation: There is no evidence of a breakout having occurred yet; the setup remains in the "Forming" phase.
• Detailed SHOP Metrics: While the SHOP platform is mentioned, specific yield or occupancy metrics for the SHOP assets are not detailed in the provided evidence, limiting the ability to fully value the diversification benefit.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: 14% year-over-year FFO per share growth and 16.4% dividend increase; Investment grade upgrade by Moody's; $1.1 billion in investments closed year-to-date at 8.9% blended yield. Key risks: Setup remains in "Forming" state with no confirmed breakout; reliance on tenant credit quality in the skilled nursing sector; potential regulatory headwinds from CMS payment updates if finalized rates are lower than expected. Sizing hint: Position size should be conservative given the unconfirmed setup; treat as a partial position pending breakout confirmation. Expected path: Management expects continued deployment of the $360 million pipeline and integration of the SHOP platform to drive FFO growth; the stock likely consolidates or grinds higher as the forming coil matures, awaiting a catalyst to trigger the breakout. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation).